Structures by: Essassi E. M.

Total: 358

4-Benzylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine

C12H10N4S

El Fal, MohammedRamli, YoussefEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 11 o1650

a=9.4737(3)Å   b=5.1709(2)Å   c=23.6159(8)Å

α=90.00°   β=96.8230(10)°   γ=90.00°

1-Octylindoline-2,3-dione

C16H21NO2

Qachchachi, Fatima-ZahraeKandri Rodi, YoussefEssassi, El MokhtarKunz, WernerEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 12 o1801

a=20.266(4)Å   b=4.69250(10)Å   c=15.7807(11)Å

α=90.00°   β=108.941(18)°   γ=90.00°

Ethyl 2-{5-[(3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate

C15H16N4O3S

Sebbar, Nada KheiraZerzouf, AbdelfettahEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 2 o116

a=5.6414(2)Å   b=11.1604(4)Å   c=13.3724(5)Å

α=73.823(2)°   β=87.226(2)°   γ=88.566(2)°

3-Hexadecyl-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione

C27H44N2O2

Dardouri, RachidaRodi, Youssef KandriLadeira, SoniaEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 5 o1155

a=8.14260(10)Å   b=36.2705(5)Å   c=9.40900(10)Å

α=90.00°   β=114.6110(10)°   γ=90.00°

1-Octyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C15H22N2O

Belaziz, DouniaKandri Rodi, YoussefEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2012) 68, 5 o1276

a=14.8888(18)Å   b=5.8395(6)Å   c=16.6778(19)Å

α=90.00°   β=91.448(3)°   γ=90.00°

(3<i>R</i>,4<i>S</i>)-3,4,8-Trihydroxy-1,2,3,4-tetrahydronaphthalen-1-one monohydrate

C10H10O4,H2O

Ouchbani, TarikZouihri, HafidEssassi, El MokhtarProksch, PeterNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 6 o1874

a=4.6430(4)Å   b=14.3904(11)Å   c=14.4976(10)Å

α=90.00°   β=90.00°   γ=90.00°

1,1''-Bis(prop-2-en-1-yl)-1,1'',2,2''-tetrahydrodispiro[indole-3,7'- [6,9]diazatricyclo[7.3.0.0^2,6^]dodecane-8',3''-indole]-2,2''-dione

C30H32N4O2

Al Mamari, KhalilEnnajih, HamidBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 6 o1637

a=14.9484(2)Å   b=9.91730(10)Å   c=17.5713(3)Å

α=90.00°   β=111.1190(10)°   γ=90.00°

5,5''-Dibromo-1,1''-bis(prop-2-en-1-yl)-1,1'',2,2''-tetrahydrodispiro[indole- 3,7'-[6,9]diazatricyclo[7.3.0.0^2,6^]dodecane-8',3''-indole]-2,2''-dione

C30H30Br2N4O2

Al Mamari, KhalilEnnajih, HamidBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 6 o1638

a=14.1658(3)Å   b=9.7203(2)Å   c=20.6677(3)Å

α=90.00°   β=100.0370(10)°   γ=90.00°

4-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one

C18H16N4OS

Sebbar, Nada KheiraZerzouf, AbdelfettahEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 2 o160-o161

a=13.283(2)Å   b=5.3661(10)Å   c=23.281(4)Å

α=90.00°   β=96.633(10)°   γ=90.00°

Ethyl 2-(2-amino-5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)acetate

C10H13N5O2

Gueddar, HichamBouhfid, RachidGuessous, Ahmed RadouaneEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 1 o239

a=22.9635(4)Å   b=7.74470(10)Å   c=14.7017(3)Å

α=90.00°   β=124.5740(10)°   γ=90.00°

5-Bromo-1-(prop-2-en-1-yl)-2,3-dihydro-1<i>H</i>-indole-2,3-dione

C11H8BrNO2

Maamri, KhalilZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 1 o240

a=31.3411(5)Å   b=7.89950(10)Å   c=8.27160(10)Å

α=90.00°   β=90.00°   γ=90.00°

3-{2-[(3-{(<i>E</i>)-2-[4-(Dimethylamino)phenyl]ethenyl}quinoxalin-2- yl)oxy]ethyl}-1,3-oxazolidin-2-one monohydrate

C23H24N4O3,H2O

Ramli, YoussefZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 1 o241

a=7.209800(10)Å   b=23.3271(4)Å   c=12.3994(2)Å

α=90.00°   β=98.1190(10)°   γ=90.00°

3-Hydroxy-4-phenyl-1-(prop-2-en-1-yl)-2,3,4,5-tetrahydro-1<i>H</i>- 1,5-benzodiazepin-2-one

C18H18N2O2

Rida, MohamedMamari, KhalilEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 1 o238

a=51.6665(8)Å   b=14.5766(2)Å   c=11.9316(2)Å

α=90.00°   β=90.965(2)°   γ=90.00°

2-Phenylthieno[2,3-<i>b</i>]quinoxaline

C16H10N2S

Ramli, YoussefZouihri, HafidAzougagh, MohamedMoussaif, AhmedEssassi, El Mokhtar

Acta Crystallographica Section E (2012) 68, 2 o396

a=6.3875(3)Å   b=16.2896(8)Å   c=11.6054(6)Å

α=90.00°   β=96.039(3)°   γ=90.00°

1-(Prop-2-ynyl)-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C10H8N2O

Ouzidan, YounèsKandri Rodi, YoussefOuazzani Chahdi, FouadEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 1 o119

a=4.5553(6)Å   b=18.001(3)Å   c=10.7488(13)Å

α=90.00°   β=93.645(8)°   γ=90.00°

Bis[1-benzyl-2-(1,3-thiazol-4-yl)-1<i>H</i>-benzimidazole- κ^2^<i>N</i>^2^,<i>N</i>^3^]dichloridocobalt(II)

C34H26Cl2CoN6S2

Gueddar, HichamBouhfid, RachidEssassi, El MokhtarEl Brahmi, NabilEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 1 m5-m6

a=10.1311(3)Å   b=11.9582(4)Å   c=14.2633(5)Å

α=76.033(3)°   β=75.536(3)°   γ=69.707(3)°

1-(4-Methylbenzyl)-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C15H14N2O

Belaziz, DouniaKandri Rodi, YoussefOuazzani Chahdi, FouadEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 1 o122

a=12.5585(5)Å   b=5.7181(2)Å   c=17.4153(7)Å

α=90.00°   β=95.277(2)°   γ=90.00°

1-Benzyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C14H12N2O

Ouzidan, YounesEssassi, El MokhtarLuis, Santiago V.Bolte, MichaelEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 7 o1822

a=13.8652(7)Å   b=5.7975(3)Å   c=14.9337(7)Å

α=90.00°   β=109.5346(12)°   γ=90.00°

Di-<i>tert</i>-butyl 2,6,11-trioxo-2,3-dihydro-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-1,3-diacetate

C27H28N2O7

Afrakssou, ZahraRodi, Yousef KandriSaffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 7 o1730

a=19.5785(4)Å   b=13.0330(3)Å   c=9.9269(2)Å

α=90.00°   β=90.5830(10)°   γ=90.00°

3-{[3-(4-Methoxyphenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}- 1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione

C22H23N3O4

Dardouri, RachidaRodi, Yousef KandriSaffon, NatalieEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 7 o1729

a=28.0041(5)Å   b=15.4644(3)Å   c=9.0350(2)Å

α=90.00°   β=93.2350(10)°   γ=90.00°

2-(3<i>H</i>-1,3-Benzothiazol-2-ylidene)propanedial

C10H7NO2S

Ennajih, HamidBouhfid, RachidMassip, StephaneLeger, Jean MichelEssassi, El Mokhtar

Acta Crystallographica Section E (2011) 67, 9 o2260

a=8.3927(10)Å   b=5.0972(8)Å   c=20.739(2)Å

α=90.00°   β=100.098(8)°   γ=90.00°

2-[3-(1<i>H</i>-Benzimidazol-2-yl)propyl]-1-decyl-1<i>H</i>-benzimidazole

C27H36N4

Ennajih, HamidBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 9 o2544

a=38.5580(6)Å   b=13.2052(2)Å   c=9.9623(2)Å

α=90.00°   β=95.3390(10)°   γ=90.00°

4-(1,3-Benzothiazol-2-yl)-1,5-dimethyl-2-phenyl-1<i>H</i>-pyrazol- 3(2<i>H</i>)-one

C18H15N3OS

Chakib, ImaneZerzouf, AbdelfettahRodi, Youssef KandriEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 10 o2700

a=8.7428(2)Å   b=25.7551(5)Å   c=6.96600(10)Å

α=90.00°   β=97.4600(10)°   γ=90.00°

6-Bromoimidazo[1,2-<i>a</i>]pyridin-8-amine

C7H6BrN3

Dahmani, SihamKandri Rodi, YoussefCapet, FredericEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 11 o2838

a=15.1378(5)Å   b=21.2006(8)Å   c=6.9744(3)Å

α=90.00°   β=92.6106(7)°   γ=90.00°

1,3-Dibenzyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C21H18N2O

Kandri Rodi, YoussefOuazzani Chahdi, FouadEssassi, El MokhtarLuis, Santiago V.Bolte, MichaelEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 12 o3234

a=19.5983(7)Å   b=9.0882(2)Å   c=10.0473(3)Å

α=90.00°   β=115.593(4)°   γ=90.00°

5-Chloro-1-nonyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C16H23ClN2O

Kandri Rodi, YoussefOuazzani Chahdi, FouadEssassi, El MokhtarLuis, Santiago V.Bolte, MichaelEl Ammari, Lahcen

Acta Crystallographica Section E (2011) 67, 12 o3340-o3341

a=5.51441(17)Å   b=15.6507(4)Å   c=20.0540(6)Å

α=71.807(3)°   β=86.612(2)°   γ=80.709(2)°

5-Acetyl-3-hydroxy-4-phenyl-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin- 2(3<i>H</i>)-one

C17H16N2O3

Rida, MohamedAlsubari, AbdusalamEssassi, El MokhtarZouihri, HafidNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 12 o3337

a=8.97100(10)Å   b=9.31420(10)Å   c=9.41290(10)Å

α=81.5630(10)°   β=68.9210(10)°   γ=80.1460(10)°

3-Bromo-6-nitro-1-(prop-2-ynyl)-1<i>H</i>-indazole

C10H6BrN3O2

El Brahmi, NabilBenchidmi, MohamedEssassi, El MokhtarLadeira, SoniaNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 12 o3260

a=14.6573(3)Å   b=4.16500(10)Å   c=17.4566(3)Å

α=90.00°   β=102.6590(10)°   γ=90.00°

1-Benzyl-3-methyl-3',5'-diphenylspiro[quinoxaline-2(1<i>H</i>),2'(3'<i>H</i>)- 1,3,4-thiadiazole]

C29H24N4S

Anothane, Caleb AhoyaBouhfid, RachidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 1 o103

a=13.5441(2)Å   b=14.8971(2)Å   c=15.0149(2)Å

α=66.4310(10)°   β=63.9210(10)°   γ=65.2750(10)°

5-Nitro-1-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one

C10H7N3O3

Ouzidan, YounesKandri Rodi, YoussefZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2012) 68, 4 o1240

a=7.2541(2)Å   b=10.0362(2)Å   c=14.6793(3)Å

α=100.9780(10)°   β=92.0470(10)°   γ=109.0430(10)°

1-Allyl-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one

C10H10N2O

Belaziz, DouniaKandri Rodi, YoussefOuazzani Chahdi, FouadEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2012) 68, 11 o3212

a=10.2749(5)Å   b=5.5787(3)Å   c=16.6220(9)Å

α=90.00°   β=100.976(4)°   γ=90.00°

1-Dodecyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one

C19H30N2O

Belaziz, DouniaKandri Rodi, YoussefOuazzani Chahdi, FouadEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2012) 68, 11 o3069

a=38.3223(14)Å   b=4.8318(2)Å   c=21.9831(8)Å

α=90.00°   β=117.843(2)°   γ=90.00°

1-Allyl-6-nitro-1<i>H</i>-indazole

C10H9N3O2

El Brahmi, NabilBenchidmi, MohammedEssassi, El MokhtarLadeira, SoniaEl Ammari, Lahcen

Acta Crystallographica Section E (2012) 68, 12 o3368

a=4.3630(16)Å   b=8.3245(7)Å   c=13.541(5)Å

α=95.647(2)°   β=98.46(2)°   γ=97.770(2)°

1-Allyl-5-nitro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

C10H9N3O3

Ouzidan, YounèsKandri Rodi, YoussefKandri Rodi, AdibaEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 3 o431

a=8.3246(3)Å   b=14.9567(6)Å   c=16.4461(7)Å

α=90.00°   β=90.00°   γ=90.00°

1-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]indoline-2,3-dione

C18H14N4O2

Qachchachi, Fatima-ZahraeKandri Rodi, YoussefEssassi, El MokhtarBodensteiner, MichaelEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 5 o588

a=11.53860(18)Å   b=5.38700(9)Å   c=23.2433(4)Å

α=90.00°   β=92.1048(16)°   γ=90.00°

Bis(1-benzyl-1<i>H</i>-benzimidazole-κ<i>N</i>^3^)dichloridozinc

C28H24Cl2N4Zn

Bouhfid, RachidEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 3 m94-m95

a=9.9819(4)Å   b=10.0564(4)Å   c=13.6641(6)Å

α=99.539(2)°   β=92.087(2)°   γ=99.122(2)°

3-[2-(3-Phenyl-2-oxo-1,2-dihydroquinoxalin-1-yl)ethyl]-1,3-oxazolidin-2-one

C19H17N3O3

Daouda, BalloDoumbia, Mouhamadou LamineEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 5 o662

a=9.6314(5)Å   b=16.6596(9)Å   c=10.0749(5)Å

α=90.00°   β=98.097(3)°   γ=90.00°

7-Chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidine

C13H10ClN3

Bassoude, IbtissamBerteina-Raboin, SabineEssassi, El MokhtarGuillaumet, GéraldEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 5 o749

a=6.5993(2)Å   b=12.6166(4)Å   c=13.8702(5)Å

α=90.00°   β=100.131(2)°   γ=90.00°

<i>N</i>-(2-Bromo-4-methylphenyl)-2-(5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)acetamide

C22H19BrN4O

Bassoude, IbtissamBerteina-Raboin, SabineEssassi, El MokhtarGuillaumet, GéraldEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 6 o829

a=9.8102(6)Å   b=7.2915(4)Å   c=27.0162(14)Å

α=90.00°   β=92.942(3)°   γ=90.00°

Ethyl 2-oxo-3-(3-phthalimidopropyl)-2,3-dihydro-1<i>H</i>-1,3-benzimidazole-1-carboxylate

C21H19N3O5

Belaziz, DouniaKandri Rodi, YoussefKandri Rodi, AdibaEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 5 o641-o642

a=5.2850(7)Å   b=10.6663(12)Å   c=16.505(2)Å

α=86.454(7)°   β=83.424(8)°   γ=89.376(7)°

Ethyl 7-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidine-5-carboxylate

C16H15N3O2

Bassoude, IbtissamBerteina-Raboin, SabineEssassi, El MokhtarGuillaumet, GéraldEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 5 o740

a=8.0542(8)Å   b=16.4104(19)Å   c=21.635(2)Å

α=90.00°   β=90.00°   γ=90.00°

3-Benzyl-6-bromo-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C13H10BrN3O

Kandri Rodi, YoussefHaoudi, AmalCapet, FrédéricMazzah, AhmedEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 6 o962

a=4.2399(2)Å   b=10.4463(4)Å   c=14.5144(6)Å

α=107.611(2)°   β=90.628(3)°   γ=99.784(3)°

1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-dihydroisoxazol-5-yl]methyl}-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione

C27H20N4O4

Afrakssou, ZahraKandri Rodia, YoussefCapet, FrédéricEssassi, El MokhtarRolando, ChristianEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 6 o945-o946

a=8.0930(2)Å   b=12.1191(3)Å   c=12.2743(2)Å

α=87.1090(10)°   β=73.6120(10)°   γ=72.2830(10)°

6-Bromo-1,3-bis[(1,3-dioxolan-2-yl)methyl]-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C14H16BrN3O5

Kandri Rodi, YoussefHaoudi, AmalCapet, FrédéricMazzah, AhmedEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 7 o1029-o1030

a=5.11440(10)Å   b=17.8029(4)Å   c=16.5365(5)Å

α=90.00°   β=97.009(2)°   γ=90.00°

<i>N</i>'-Phenyl-<i>N</i>'-[3-(2,4,5-triphenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)quinoxalin-2-yl]benzohydrazide

C42H32N6O

Ramli, YoussefKarrouchi, KhalidEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 8 o1320-o1321

a=12.0127(3)Å   b=19.4679(5)Å   c=15.2083(4)Å

α=90.00°   β=106.0450(10)°   γ=90.00°

<i>N</i>'-(3-Sulfanylidene-3,4-dihydroquinoxalin-2-yl)benzohydrazide dimethylformamide monosolvate

C15H12N4OS,C3H7NO

Zanzoul, AsmaeEssassi, El MokhtarPratviel, GenevièveSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2013) 69, 8 o1268

a=10.4053(2)Å   b=16.8563(5)Å   c=10.3624(2)Å

α=90.00°   β=100.882(2)°   γ=90.00°

3-(2,3-Dioxoindolin-1-yl)propanenitrile

C11H8N2O2

Qachchachi, Fatima-ZahraeKandri Rodi, YoussefEssassi, El MokhtarBodensteiner, MichaelEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 3 o361-o362

a=7.1967(2)Å   b=9.9909(3)Å   c=13.5534(5)Å

α=77.508(3)°   β=81.551(3)°   γ=77.717(3)°

4-[(1-Benzyl-1,2,3-triazol-5-yl)methyl]-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one

C18H16N4OS

Sebbar, Nada KheiraEl Fal, MohammedEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 3 o363-o364

a=34.5438(15)Å   b=6.0102(2)Å   c=15.6138(7)Å

α=90.00°   β=90.00°   γ=90.00°

(2<i>Z</i>)-2-Benzylidene-4-(prop-2-yn-1-yl)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one

C18H13NOS

Sebbar, Nada KheiraZerzouf, AbdelfettahEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 5 o614

a=9.0254(13)Å   b=7.7388(12)Å   c=42.488(7)Å

α=90.00°   β=90.00°   γ=90.00°

1-Ethylpyrazolo[3,4-<i>d</i>]pyrimidine-4(5<i>H</i>)-thione

C7H8N4S

El Fal, MohammedRamli, YoussefEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 9 o1005-o1006

a=4.472(4)Å   b=5.353(4)Å   c=17.573(12)Å

α=90.00°   β=93.71(4)°   γ=90.00°

4-Allylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine

C8H8N4S

El Fal, MohammedRamli, YoussefEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2014) 70, 9 o1038

a=18.537(6)Å   b=5.1997(17)Å   c=19.059(7)Å

α=90.00°   β=90.00°   γ=90.00°

2-(Benzylsulfanyl)-4-phenyl-3<i>H</i>-1,5-benzodiazepine

C22H18N2S

Doubia, Mohamadou LamineBouhfid, RachidAhabchane, Noureddine HamouEssassi, El MokhtarEl Ammari, Lahcen

Acta Crystallographica Section E (2007) 63, 7 o3305-o3305

a=8.9633(2)Å   b=8.4904(2)Å   c=23.1997(5)Å

α=90.00°   β=92.2060(10)°   γ=90.00°

1,3-Dibenzyl-6-bromo-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

C20H16BrN3O

Dahmani, S.Kandri Rodi, Y.Capet, F.Essassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 4 o754

a=9.16270(10)Å   b=25.5071(3)Å   c=8.06290(10)Å

α=90.00°   β=115.5710(10)°   γ=90.00°

1,3-Diallyl-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione

C21H16N2O3

Afrakssou, ZahraRodi, Youssef KandriZouihri, HafidEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2010) 66, 7 o1851

a=7.8539(2)Å   b=11.5822(3)Å   c=18.1455(4)Å

α=90.00°   β=93.5370(10)°   γ=90.00°

1,3-Bis(naphthalen-2-ylmethyl)-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole- 2,6,11(3<i>H</i>)-trione

C37H24N2O3

Afrakssou, ZahraRodi, Youssef KandriCapet, FrédéricEssassi, El MokhtarNg, Seik Weng

Acta Crystallographica Section E (2011) 67, 8 o2138

a=8.09010(10)Å   b=12.8226(2)Å   c=26.1472(4)Å

α=90.00°   β=90.00°   γ=90.00°

7-phenyl-1,4-diazepin-5-one monohydrate

C11H14N2O2

Chemmache, M.Essassi, E.M.Pierrot, M.

Zeitschrift für Kristallographie - New Crystal Structures (2001) 216, 1 101-102

a=7.1014(4)Å   b=8.6896(7)Å   c=10.1265(8)Å

α=70.175(3)°   β=88.517(5)°   γ=66.283(4)°

C24H34Cl2N8O12Zn0.5

C24H34Cl2N8O12Zn0.5

Chkirate, K.Regragui, R.Essassi, E. M.Pierrot, M.

Zeitschrift für Kristallographie - New Crystal Structures (2001) 216, 4 635-636

a=15.7901(6)Å   b=11.5163(4)Å   c=20.1992(6)Å

α=90.000(1)°   β=154.373(3)°   γ=90.000(1)°